Argent Biopharma(AU:RGT)
A$0.02+0.00 (+10.53%)
AU:RGT
Argent Biopharma technical analysis
A$0.02
At close:+0.00 (+10.53%)
Want to see AU:RGT full AI Analyst Report?
Argent Biopharma (RGT) Technical Analysis
7 Followers
Technical Sentiment
Overall ConsensusStrong Sell Strong Buy Sell
12Bearish
5Neutral
5Bullish
Technical Analysis ConsensusStrong Sell Strong Buy Neutral
2Bearish
5Neutral
3Bullish
Moving Average ConsensusStrong Sell Strong Buy Strong Sell
10Bearish
0Neutral
2Bullish
1 Day timeframe · Data as of Nov 13, 2026
- Argent Biopharma’s (RGT) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Argent Biopharma is a Buy.
- Argent Biopharma’s (RGT) 20-Day exponential moving average is 0.02, while Argent Biopharma’s (RGT) share price is AU$0.02, making it a Sell.
- Argent Biopharma’s (RGT) 50-Day exponential moving average is 0.03, while Argent Biopharma’s (RGT) share price is AU$0.02, making it a Sell.
Argent Biopharma (RGT) Pivot Points
1 Day timeframe · Data as of Nov 13, 2026
| Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Classic | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Fibonacci | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
Argent Biopharma (RGT) Moving Averages
1 Day timeframe · Data as of Nov 13, 2026
| Period | Simple | Exponential |
|---|---|---|
| MA5 | 0.02Buy | 0.02Buy |
| MA10 | 0.02Sell | 0.02Sell |
| MA20 | 0.02Sell | 0.02Sell |
| MA50 | 0.03Sell | 0.03Sell |
| MA100 | 0.04Sell | 0.03Sell |
| MA200 | 0.04Sell | 0.04Sell |
- Argent Biopharma’s (RGT) 10-Day exponential moving average is 0.02, while Argent Biopharma’s (RGT) share price is AU$0.02, making it a Sell.
- Argent Biopharma’s (RGT) 100-Day exponential moving average is 0.03, while Argent Biopharma’s (RGT) share price is AU$0.02, making it a Sell.
- Argent Biopharma’s (RGT) stock price is AU$0.02 and Argent Biopharma’s (RGT) 50-day simple moving average is 0.03, creating a Sell signal.
- Argent Biopharma’s (RGT) stock price is AU$0.02 and Argent Biopharma’s (RGT) 100-day simple moving average is 0.04, creating a Sell signal.
- Argent Biopharma’s (RGT) stock price is AU$0.02 and Argent Biopharma’s (RGT) 200-day simple moving average is 0.04, creating a Sell signal.
Argent Biopharma (RGT) Technical Indicators
1 Day timeframe · Data as of Nov 13, 2026
| Name | Value | Implied Action |
|---|---|---|
| RSI (14) | 39.18 | Neutral |
| STOCH (9,6) | 33.33 | Neutral |
| STOCHRSI (14) | 23.33 | Neutral |
| MACD (12,26) | >-0.01 | Buy |
| ADX (14) | 15.49 | Buy |
| Williams %R | -60.00 | Buy |
| CCI (14) | -63.02 | Neutral |
| ATR (14) | <0.01 | - |
| Ultimate Oscillator | 45.87 | Neutral |
| ROC | -27.59 | Sell |
- Argent Biopharma’s (RGT) Relative Strength Index (RSI) is 39.18, creating a Neutral signal.
- Argent Biopharma’s (RGT) Trend Strength Indicator (ADX) is 15.49, creating a Buy signal.
- Argent Biopharma’s (RGT) Commodity Channel Index (CCI) is -63.02, creating a Neutral signal.
- Argent Biopharma’s (RGT) Price Rate of Change (ROC) is -27.59, creating a Sell signal.
unique trading strategy with a flexible screenerTry it Now!
FAQ
Is RGT a Buy, Hold, or Sell?
Based on RGT’s technical indicators on the 1-day timeframe as of Nov 13, 2026, RGT is a Sell.
What is RGT’s RSI (14)?
RGT’s RSI (14) is 39.18, which suggests RGT is a Neutral.
What is RGT’s MACD?
RGT’s MACD is >-0.01, which suggests RGT is a Buy.
What is RGT’s 5-day moving average?
RGT’s 5-day moving average is 0.02, which suggests RGT is a Buy.
What is RGT’s 20-day moving average?
RGT 20-day moving average is 0.02, which suggests RGT is a Sell.
What is RGT’s 50-day moving average?
RGT’s 50-day moving average is 0.03, which suggests RGT is a Sell.
What is RGT’s 200-day moving average?
RGT’s 200-day moving average is 0.04, which suggests RGT is a Sell.
What is RGT’s Williams % R (14)?
RGT’s Williams % R (14) is -60.00, which suggests RGT is a Buy.
What is RGT’s CCI (14)?
RGT’s CCI (14) is -63.02, which suggests RGT is a Neutral.
What is the share price of Argent Biopharma?
Argent Biopharma's share price is N/AAU$.

